{
  "pmid": "36191324",
  "uid": "36191324",
  "title": "In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status.",
  "abstract": "Filippatos G, Butler J, Farmakis D, et al. Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes. Circulation. 2022;146:676-86. 35762322.",
  "authors": [
    {
      "last_name": "Fudim",
      "fore_name": "Marat",
      "initials": "M",
      "name": "Marat Fudim",
      "affiliations": [
        "Duke University, Durham, North Carolina, USA (M.F.)."
      ]
    },
    {
      "last_name": "Van Spall",
      "fore_name": "Harriette G C",
      "initials": "HGC",
      "name": "Harriette G C Van Spall",
      "affiliations": [
        "McMaster University, Hamilton, Ontario, Canada (H.G.S.)."
      ]
    }
  ],
  "journal": {
    "title": "Annals of internal medicine",
    "iso_abbreviation": "Ann Intern Med",
    "issn": "1539-3704",
    "issn_type": "Electronic",
    "volume": "175",
    "issue": "10",
    "pub_year": "2022",
    "pub_month": "Oct"
  },
  "start_page": "JC111",
  "pages": "JC111",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Comment"
  ],
  "keywords": [
    "Benzhydryl Compounds",
    "Diabetes Mellitus",
    "Glucosides",
    "Heart Failure",
    "Hospitalization",
    "Humans",
    "Stroke Volume",
    "Ventricular Function, Left"
  ],
  "article_ids": {
    "pubmed": "36191324",
    "doi": "10.7326/J22-0075"
  },
  "doi": "10.7326/J22-0075",
  "dates": {
    "completed": "2022-10-19",
    "revised": "2023-01-22"
  },
  "chemicals": [
    "Benzhydryl Compounds",
    "Glucosides",
    "empagliflozin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T15:04:22.884051",
    "pmid": "36191324"
  }
}